Carm is one of the founders of RxRevu and leads the organization as CEO. He has a diverse background in technology, with specific expertise in new product development. His entrepreneurial spirit began in high school when he developed his first web hosting company and sold it to investors in 2001. After graduating from Northeastern University with a degree in Electrical Engineering, Carm served in key leadership positions at a variety of consumer-focused technology start-ups including as Chief Technology Officer at two successive organizations.
He was inspired to create RxRevu and take on the challenges of Health Information Technology in 2013. Since that time, he has made transforming the value of healthcare through better prescription decisions both his and the organization’s shared mission. Alongside his team, he leads the industry in taking Prescription Decision Support from a concept to a marketable reality for physicians, payers and health systems.
Carm is a passionate thought leader and has presented at dozens of healthcare innovation conferences and summits. He brings a fresh, collaborative and solution-oriented viewpoint to legacy healthcare challenges. He resides in the front range of the Colorado Rockies with his wife, a sports medicine physician and pediatrician, and his two young sons.
Kyle is responsible for the commercial strategy at RxREVU. He has spent much of the past decade responding to shifts in the healthcare value chain through a variety of growth-related roles in some of the country’s most innovative health and wellness firms, including Principal Wellness Company, Welltok and Catapult Health. Kyle earned a business degree from Guilford College in North Carolina, where he also played football. He started his career working for payers where he developed previously stagnant territories and created significant value for those organizations.
Kyle transitioned his focus to supporting healthcare start-ups. He sought out and built critical partnerships with the nation’s largest payers, managed key relationships, and helped position the organizations he served for long-term sustainable growth. He joined RxRevu in 2015 to support translating the academic research and technology platform that the early-stage company had developed into a marketable reality. Today he sets the strategic direction for RxRevu’s Prescription Decision Support growth and continues to build partnerships across the value chain.
Kyle is dedicated to improving the US healthcare system through technological innovations, and is a sought-after speaker and presenter on local and national stages. He has recently relocated to Seattle, Washington with his wife, Carly, who is an investment banker and his daughter, Audrey.
Peregrin Marshall is one of the founders of RxRevu and leads the product and development teams as Chief Technology Officer. Since 2013, he has been responsible for the overall platform and data infrastructure at RxRevu.
Peregrin has 20 years of application and start-up experience. He is a web architect and team leader, specializing in software development and product design. He has been able to collaborate closely with physicians and scientists, bridging the gap between technology and evidence-based medicine. He has been a key contributor to CDS Hooks, a standard for event-driven clinical decision support.
After earning a degree in Psychology and Art History from the University of California (Santa Cruz), Peregrin worked in the aviation industry while furthering his coding skills by launching multiple web-based startups and serving as a consultant, creating web assets for national brands.
Working with engineers from leading EHRs, he is bringing the power of big data and the agility of the web to the EHR experience. Through his experience in working with a variety of vendors, including Epic, Cerner, Athena Health, and Avatar, he has used technology and 3rd party data to improve clinical outcomes and improve provider efficiency. Peregrin lives in Denver, Colorado.
Dr. Kevin O’Brien is one of the founders of RxRevu and provides clinical leadership to the organization as its Chief Medical Officer. With 25 years of experience in primary care and as an allergy specialist, Dr. O’Brien has been a critical influence in the provider experience and perspective in the development of RxRevu’s Prescription Decision Support (PDS) technology.
Having served 7 years as the Medical Director for Healthy Advice Networks (Patient Point), Dr. O’Brien is an expert in physician education programs. He has specific focused experience in product development regarding physician prescribing habits and patient medication adherence. He has invented and patented several medical innovations and programs including: an automatic zone system for an asthma device; the first asthma disease management program for Kaiser Permanente; the first national asthma disease management program for Prudential; the first patient education TV network; and the underlying proof of concept and clinical decision protocols that fuel RxRevu’s PDS technology.
Dr. O’Brien has earned a degree in Nutrition from The University of Texas (Austin), his Doctor of Medicine (MD) from The University of Texas (Houston), and has a Fellowship in Allergy, Asthma and Immunology from the University of Cincinnati College of Medicine. He resides in Highlands Ranch, Colorado where he lives with his spouse Amy. His three children are completing college or recent graduates.
Dr. Blakeslee provides clinical leadership to the organization as the Head of Research and Clinical Outcomes. He is responsible for the clinical validity of RxRevu’s revolutionary Prescription Decision Support (PDS) technology, ensuring that the platform is poised to drive improvements in patient outcomes and clinical workflow. His unique credentials contribute to the development of actionable features in the platform’s point-of-care interface, as well as fostering collaborations with major research institutions, health systems and universities.
In addition to Dr. Blakeslee’s clinical oversight of RxRevu’s PDS technology, he also has secured significant grant funding for the organization, supporting the expansion of the functionality of PDS through critical academic and medical partnerships. Specific opportunities have come from the NIH’s Small Business Innovation Research (SBIR) grants and state-funded healthcare and bioscience initiatives, such as the Colorado Office of Economic Development and International Trade (CO OEDIT). Most recently, he represented RxRevu at the Office of the National Coordinator for Health Information Technology (ONC) 2017 Interoperability in Action day, held by the ONC Tech Lab, where he presented on RxRevu’s featured High Impact Pilot project.
Prior to earing his PhD, Dr. Blakeslee earned his undergraduate degree in Biochemistry from the University of Colorado (Boulder). Prior to joining RxRevu, his research experience spanned the entire gamut of pre-clinical drug development to conducting clinical trials. He served as a Biomedical Advisor for Corvectra, and a Scientific Advisor at Test Appropriate. He resides in Denver, Colorado.
Aaron provides finance and accounting leadership at RxRevu as Chief Financial Officer. He oversees the management of all financial, governance and strategic human resource functions for the organization. He brings nearly two decades of experience working with high-growth, venture backed start-up companies and has served as CFO at several organizations in the past including Explorys (an IBM company), YouDocs Beauty and Axentis.
As Principal of his own consulting firm, Cornell Financial Consulting, he has had the opportunity to work with a wide variety of companies in areas such as: M&A due diligence, equity and debt raising, strategic planning, compliance and risk management, board engagement, and contract negotiation among other areas.
Aaron is actively involved in multiple innovating and community-oriented endeavors. Currently, he serves as a Managing Partner of the Gypsy Brewery and is the co-founder of the Cleveland Concert Company. He serves on the board of the Urban Community School and he and his wife are actively involved with the Cleveland Food Bank. He is also the co-founder and CFO of Tech Elevator, an immersive computer programming bootcamp.
Aaron has an undergraduate degree in Finance from Youngstown State University, where he graduated magna cum laude, and minored in Accounting, Economics and Psychology.
Nic provides operational and account management leadership at RxRevu as the Director of Client Projects. He serves as the organization’s lead implementation manager where he focuses on project stakeholder engagement, project milestone execution, consulting, third-party business development, launch support and ongoing training and education for users and clients.
Prior to joining RxRevu, Nic served for 4 years as an Operations Manager at TempTRIP, a subsidiary of Sealed Air Corporation. There he closed and managed key sales, facilitated the integration and implementation process, streamlined the company’s international distribution process, and performed various reporting and analytics functions. At TempTRIP, he worked with elite organizations in pharmacy and medical device distribution, gaining invaluable direct experience in the healthcare industry.
Nic earned his BA in Economics with an emphasis in Business at the University of Colorado (Boulder). After gaining operations experience for several years, he attended Arizona State University where he received his MBA with emphases on Health Sector Management and Finance. He currently resides in Denver, Colorado.
Bruce Donaldson is a business development leader at RxRevu with prominent experience in growing start-up organizations in the healthcare and technology industries. He shapes the organization’s near and long-term growth strategies with providers and payers, and defines deal structure and agreements. He has also launched relationships with EHR vendors, securing the agreements needed for RxRevu’s Prescription Decision Support technology to be put into use at the point of care. Bruce brings practical wisdom and an insightful approach to the full-funnel sales and implementation process, and is closely involved in RxRevu’s IP and data strategy.
Prior to joining RxRevu, Bruce had an accomplished professional career building valuable organizations and supporting innovations in engineering, science, technology, logistics and healthcare. From 1991 to 2000, he served as CEO of WITI Corporation, a private company that successfully commercialized IP from a large federal laboratory. While leading the company, Deloitte and Touche named WITI Corporation one of the 500 fastest growing tech companies in the US. Among many other C-level leadership and advisory positions, Bruce was appointed to serve as interim President of the non-profit Colorado Institute of Technology. He successfully partnered with elected officials and other individuals to implement strategic options and lead an efficient redeployment of the organization’s assets.
Bruce received a bachelor’s degree in mechanical engineering (with highest honors) from Purdue University and an MBA from the Harvard Business School. Bruce resides in Broomfield, Colorado, with his wife and family where he is an active member of his local community.
Joel Longtine is a member of the product and development team working as a Senior Software Engineer at RxRevu. He has nearly a decade of experience, with a demonstrated history of tackling challenging technology opportunities in the healthcare industry. Joel manages the software delivery and infrastructure process at RxRevu, which includes HIPAA compliance, deployment and server provisioning. He is also responsible for maintaining core data sets for clients and partners.
Joel has spent the past several years supporting and leading teams at innovative organizations in software engineering and software architecture capacities. He has significant experience in full stack development, with a focus on server-side development, in Ruby/Ruby on Rails, Python, Java, Go, Agile Methodologies, AWS, Ansible and DevOps (among others). He has worked with large data systems, messaging systems, web systems, performance improvements and machine learning. Joel is experienced in managing fast-paced and fluid technology environments common to start-ups and has served organizations such as TravelShark, Epic Playground and AOL to name a few.
As a graduate of the Colorado School of Mines with focuses in Computer Science and Physics, Joel is a talented engineering professional contributing to the rapid growth of RxRevu and its Prescription Decision Support technology. Joel resides in Louisville, Colorado with his wife Kristyn and son Leander.
Sean is a member of the product and development team working as a Software Engineer. He refined his software skills at the Galvanize gSchool, through their innovative Full Stack program. Sean designs the architecture for RxRevu’s Prescription Decision Support engine and clinical configuration interfaces. He also has been the primary developer on drug pricing and eligibility.
Prior to joining RxRevu, Sean served as an analyst for venture capital firm, Invested Development, an impact investment firm focused on funding enterprises committed to serving the world’s underserved markets. There, he specialized in mobile technology and was responsible for sourcing deals and leading the due diligence process. In 2011, he opened the firm’s first international office in Nairobi, Kenya. In 2013, he built a partnership with Safaricom, the world’s largest mobile payments provider, to launch a mobile technology accelerator. He served as Program Manager for this partnership prior to moving back to the US to transition into software development and engineering.
In addition to his entrepreneurial work, Sean has had internships at top consulting firms including Bain & Company, and The Boston Consulting Group. He attended Northeastern University where he received a BSBA in Entrepreneurship, graduating Cum Laude. During this time, he also studied at the University of Ghana. Sean currently resides in Denver, Colorado.
Daniel Kramer serves RxRevu as its Senior Counsel. As the organization’s lead attorney, Daniel is responsible for contract drafting and negotiation, business strategy, intellectual property utilization, risk management and mitigation, and various other legal advisory areas. He plays a critical role in preserving and protecting the organization’s IP associated with its Prescription Decision Support technology. Dan operates under the personal credo that every business relationship will thrive so long as both parties are properly aligned and incentivized.
Daniel has ten years of experience in both medical and legal environments. His past work includes conducting academic and private scientific research, along with government and corporate general counsel positions. He was an intern at the prestigious Center for Disease Control and Prevention General Counsel at CDC headquarters in Atlanta, GA, and was the General Counsel and Healthcare Asset Manager at the University of Colorado Anschutz Medical Campus prior to joining RxRevu.
Daniel has an undergraduate degree in Biochemistry from Wake Forest University and received his Juris Doctorate degree from the University of Maryland School of Law. He also attended Heidelberg Universitate in Germany during his undergraduate studies and possesses German language skills. He currently lives in Westminster, Colorado.
Tom Groom supports RxRevu’s growth as a Strategic Advisor. He is a recognized expert and leader in healthcare information technology. His current work includes helping healthcare companies bring emerging technology to market to address population health, reducing costs and improving the patient experience. With three decades of experience in business development across a variety of healthcare, pharmacy and technology companies, Tom has helped move the industry forward through his subject matter expertise and reputation as an innovator.
Tom's background includes serving as CEO of HealthNexis, and as a Senior Director at McKesson among other well-known companies. His ability to facilitate technological connection in healthcare was honed during the 9 years he spent as the Senior Vice President of Business Development for RxHub LLC (now called Surescripts). His responsibilities there included Business Development, Marketing and Communications, as well as Federal Affairs. Along with those responsibilities, Tom provided advisory and leadership roles to e-Prescribing initiatives throughout the country, such as SEMI (SouthEast Michigan Initiative) and ePrescribe Florida. Through this work, Tom became a national public speaker for e-prescribing, and accepts invitations to speak before some of the most respected industry organizations and events.
Tom is also involved in serving on various profit and non-profit Boards. In 2015, he joined the board of directors for Tee It Up for The Troops. This position has supported his passion for leveraging his experiences and relationships in healthcare to support those that have served in the military. Tom has a bachelor’s degree from the University of Wisconsin (River Falls), and currently resides in the Twin Cities area in Minnesota.
Kevin is responsible for RxRevu’s overall account management encompassing platform deployment, implementation, support and client satisfaction. He began his career working directly with one of the industry leading EHR vendors, then transitioned to a large enterprise healthcare system before finally moving into the Healthcare IT Consulting field and eventually leading the strategic and operational responsibilities as a Managing Director. His strategic consulting experience at firms such as ACS Healthcare Solutions, Xerox and Dearborn Advisors, has been instrumental in helping clients achieve success with healthcare technology through various techniques and methods to improve clinician adoption. He has assisted large multi facility networks streamline and standardize EHR systems, helped improved technical clinician usage through workflow re-design and system configurations, and led multiple projects and initiatives including large system implementations and optimizations across the country. He specializes in collaborating with clients to leverage technology to increase patient safety, clinician efficiency and satisfaction, ultimately achieving improved patient outcomes. Kevin has a Bachelor’s Degree in Business Management from Gettysburg College.
Amy Dusek is a member of the product and development team working as a Software Engineer. Originally from Great Lakes State, Amy started out her education in the healthcare arena, graduating from the University of Michigan, Ann Arbor with a Bachelor of Science in Nursing. Shortly after graduating, Amy started working as Labor, Delivery, Recovery and Postpartum Registered Nurse, where she grew her clinical expertise and skillset.
After working in a fast-paced hospital setting, she decided to invest her energies into public health. As a Public Health Associate Fellow for the Centers for Disease Control and Prevention, Amy moved down to sunny Miami, Florida to assist local offices with their specific public health needs. She aided both the Epidemiology, Disease Control and Immunization Services and the Tuberculosis Control and Prevention Programs by assisting with disease surveillance and field investigations, conducting health assessments, providing medication therapies to clients, organizing health fairs and much more.
Stephen has a 30-year career in founding, investing in and building information technology companies. He is recognized for his leadership in data mining, analytics and business intelligence related ventures. Stephen was Founder, lead investor and served as Chairman of the Board and Chief Executive Officer of Explorys. Formed in partnership with Cleveland Clinic, Explorys addresses the national imperative to leverage electronic medical records for the improvement of Healthcare. Explorys was acquired by IBM [NYSE: IBM] in April 2015. Prior to Explorys he served as the Chairman of the Board and CEO of Everstream, the company he
founded in 1999 which was sold to Concurrent [NASDAQ: CCUR] in 2005. In 1985, Stephen founded McHale and Associates, Inc., a USConnect regional office, where he served as Chairman of the Board and CEO. He was a founding investor and served on the Board of Directors and as CEO of the parent USConnect, an international systems integrator until its sale to IKON Office Systems [NYSE: IKN] in 1997. Stephen is Managing Director of 23Bell LLC Investments and an active Advisory Board Member to Genesis Inventions.
Stephen serves on the Board of Directors for the Center for Families and Children, a non-profit organization that makes success possible for families in Northeast Ohio’s most challenged communities. Stephen serves on the investment screening committee for the North Coast Angel Fund and is a member of The Global Center for Health Innovation Industry Advisory Board. He is also an active member of the Entrepreneurs Organization and Kent State University’s Health Informatics Advisory Council.
Steven Lindseth has founded/co-founded and invested in companies in healthcare devices, technology enabled services, digital media and enterprise software. He has served on numerous boards and participated in raising dozens of rounds of equity and debt financing from both venture capital and corporate sources.
He is a senior advisor to Triple Tree, a leading healthcare technology merchant bank and private equity firm. He is on the boards of Imagescan (transactional content management), Nucleus Health, (a leader in tele- radiology and related image sharing technology) and Cleveland Clinic Innovations, which oversees innovation commercialization for that institution. He is an advisor to Healthprize, (a prescription medication adherence company), Knowledge Factor, (a leader in neuroscience-based education), Cyft (a new tool to enable anyone to build predictive models), and Fitzroy Health, (building and advising tech-enabled healthcare companies). He is a consultant to Partners Healthcare (Mass. General and Brigham & Women's Hospitals), Mercy Health, Ariadne Labs and Anschutz Medical Campus/University of Colorado.
Steve has been a founding investor in numerous prior ventures including: Dental Research Corp (the maker of the Interplak Toothbrush) which sold to Bausch & Lomb; Thermoscan (the maker of the Thermoscan Thermometer) which sold to Gilette; Complient (an outsource provider of emergency medical response services) which sold to Cardiac Science; Axentis (a provider of compliance software for the pharmaceutical industry) which sold to Wolters Kluwer; Explorys (a clinical big data management company) which sold to IBM; and YouBeauty (a women’s digital media wellness business) which sold to Caivis Holdings.
Jeffrey Patton, M.D. serves as Chief Executive Officer and Chairman of the
Board for Nashville-based Tennessee Oncology, one of the largest
community oncology practices in the U.S.
He is nationally recognized in the oncology community for his extensive
clinical trial research and scholarly publications on advancing cancer
treatment and bringing exceptional care to the communities where
patients live. Dr. Patton has published eight manuscripts and nearly 20
clinical trial abstracts on cancer treatment research. He specializes in all
adult malignancies and holds memberships in the Tennessee Oncology
Practice Society and the American Society of Clinical Oncology, where he
serves on the ASCO Clinical Practice Committee.
Dr. Patton, a graduate of Eastern Virginia Medical School in Norfolk,
completed his residency and fellowship at Wake Forest University in
Winston-Salem, N.C., where he served as Chief Resident. He also holds a
B.A. in Psychology from the University of Virginia. He currently serves as
Chairman of the Southern Oncology Board of Directors and is on the board
of directors for PearlPoint Cancer Support. He previously served as Chief of
Staff for Southern Hills Medical Center and on the board of directors for the
Sarah Cannon Research Institute.
Dr. Patton is also co-founder and Chief Medical Officer of Raintree
Oncology Services, a provider of comprehensive oral drug acquisition and
management services to help community oncology practices improve and
advance patient care.
Albert has worked with multiple Peloton Equity portfolio companies, including in deal diligence for HealthPlanOne, Inc. and Identity Theft Guard Solutions, Inc. Most significantly, Albert has served as the Chief Information and Chief Technology Officer for AeroCare Holdings, Inc. (Peloton I/FFC II), since 2014. At AeroCare, Albert is focused on technology operations, product development, and technology strategy. Prior to joining AeroCare, he served as an SVP at UnitedHealth Group, as CTO of the Optum Cloud. Prior to working with UnitedHealth, he served as CIO/CTO of Connextions Inc., a company that specialized in consumer driven healthcare solutions for payors, and was sold to Optum (a UnitedHealth Group company) in August of 2011 for approximately $350 million. Before Connextions, Albert was CIO of Rotech Medical Corporation, a publicly traded medical equipment company.
Albert is an active investor in healthcare and technology companies and and currently serves on the Board of Directors of NucleusHealth, MetisMachine, RxRevu™, HCF Enterprises and HCF Reality. Albert holds a B.A. from the University of Michigan and a M.B.A. from Rollins College
Our mission: improving the value of healthcare through better prescription decisions.learn more
To create lasting change in healthcare requires a dedicated intention and aligned effort. We are committed to investing in the future of healthcare.
Information is power and access to information empowers decision making. Transparency is required to unlock the power of information.
Accountability is taking ownership for our actions and their consequences. We support our partners and our teammates responsibly as we solve complex healthcare problems together.
We put ourselves in our partners' shoes, giving them the information they need to make complex prescribing decisions and supporting their needs.
It takes courage to innovate in healthcare. We have to take risks to succeed and sometimes that means failing. We take risks, innovate bravely and venture into unchartered territories.
At RxRevu, we support a diverse culture that values critical thinking, speaking with integrity, and contributing constructively to common goals. We assume the best intentions and value every individual.
Looking to make a difference in healthcare? Want to join a team of innovative developers, business leaders and mission-driven individuals? Join us at RxRevu.view open positions